← Back to Fund Radar
TRDA

Acciones Entrada Therapeutics Inc

US29384C1080 · TRDA (NGM)

0 value funds · 1 CNMV managers

1-year price history

Source: Yahoo Finance
- Calculating change...

The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.

Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible.

Value funds holding it
0

Of the value funds we track closely. A different universe and period from "CNMV managers": never added together.

See in Radar Fondos →
Funds (CNMV universe)
1

0 → 1 (+1) · net presence change vs. previous period

Avg. weight
1.09%
Price
4.37 USD
Sector
Healthcare
Industry
Biotechnology

CNMV data · half-year closed 2025-12-31.

Price for TRDA (NGM), updated 2026-10-18. Source: Yahoo Finance.

Funds holding this company

CNMV period H2 2025. Weight is the sum of every instrument of the company that fund holds (local share, ADR or another class), not just one.

Company-level moves

Compares H1 2025 with H2 2025, summing every instrument of the company each fund holds. A fund switching instrument within the same company doesn't show up here as an entry or exit — for that instrument-by-instrument detail, see the Instruments section.

New positions: 1 Exits: 0 Increasing exposure: 0 Reducing exposure: 0
+ ABANTE QUANT VALUE, F.I.

Enters the position at 1.09% weight.

Objective ratios

FCF yield
-28.0%
Net debt / EBITDA
1.02x
P/E
—
52-week range
5.02 – 16.45 USD

Data as-is, not an interpretation: it does not say whether the price is cheap or expensive, and it is not a buy or sell recommendation.

Updated 2026-09-06. Source: Yahoo Finance.

Disclaimer

This is not financial advice. Weights come from the periodic reports each manager files with the CNMV and lag the real close of the period. Price, description and ratios, when available, come from Yahoo Finance and may not exactly match this ISIN if the company has multiple share classes.